Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)
Crossref DOI link: https://doi.org/10.1007/s00198-016-3736-y
Published Online: 2016-09-08
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nakamura, T.
Fukunaga, M.
Nakano, T.
Kishimoto, H.
Ito, M.
Hagino, H.
Sone, T.
Taguchi, A.
Tanaka, S.
Ohashi, M.
Ota, Y.
Shiraki, M.
Funding for this research was provided by:
Asahi Kasei Pharma Corporation
License valid from 2016-09-08